Pharvaris NV
NASDAQ:PHVS
Pharvaris NV Stock, NASDAQ:PHVS
Emmy Noetherweg 2, J.H. Oortweg 21, Leiden, Zuid-Holland 2333 BK
Netherlands
Phone: +31.71.203.64.10
Number of Employees: 82
Description
Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.